Search NPCE
NeuroPace Inc
Nasdaq · CIK 1528287
Last close12.7
Daily change-0.45 (-3.42%)
10 Years gain-49.12%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NPCE · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
60.2Momentum
75.9Acceleration
85.5Confidence
83.0Annual Revenue6
Quarterly Revenue20
Annual CFO6
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth22.4 / 25
Quality18.7 / 25
Capital Efficiency7.7 / 20
Balance Sheet11.4 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 6.6178 percentage points.
Operating leverageOperating margin improved by 5.178 percentage points.
ROIC expansionROIC improved by 12.621 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Heavy share dilution · HIGHDiluted share count increased 8.3337%.
Key Metrics
Revenue Growth TTM13.32%OK
Revenue CAGR 3Y29.99%OK
Gross Margin81.02%OK
Operating Margin-23.43%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-53.07%OK
Incremental Operating Margin 3Y21.36%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y8.33%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $99.99M | $77.22M | -$16.34M | -$11.01M | -$11.34M | 77.23% | -16.34% | -11.34% | -81.59% | 32.72M |
| 2025 FY Dec 31, 2024 | $79.91M | $59.09M | -$21.67M | -$17.95M | -$18.26M | 73.94% | -27.12% | -22.85% | -132.01% | 29.13M |
| 2024 FY Dec 31, 2023 | $65.42M | $48.12M | -$27.17M | -$19.70M | -$19.87M | 73.56% | -41.54% | -30.38% | -200.3% | 25.85M |
| 2023 FY Dec 31, 2022 | $45.52M | $32.49M | -$40.79M | -$36.87M | -$37.47M | 71.38% | -89.62% | -82.32% | -357.15% | 24.59M |
| 2022 FY Dec 31, 2021 | $45.18M | $33.44M | -$23.74M | -$24.58M | -$24.96M | 74% | -52.54% | -55.24% | n/a | 16.61M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $91.75M | sum latest 4 fiscal quarters Revenue | OK | 0001528287-26-000030, 0001528287-25-000032 |
| Revenue Growth TTM | 13.32% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001528287-26-000030, 0001528287-25-000032 |
| Revenue CAGR 3Y | 29.99% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001528287-26-000011 |
| Revenue CAGR 5Y | 19.44% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001528287-26-000011 |
| Gross Profit CAGR 3Y | 33.45% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001528287-26-000011 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001528287-26-000030, 0001528287-25-000032 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 81.02% | Gross Profit / Revenue | OK | 0001528287-26-000030, 0001528287-25-000032 |
| Operating Margin | -23.43% | Operating Income / Revenue | OK | 0001528287-26-000030, 0001528287-25-000032 |
| ROIC | -53.07% | NOPAT / Average Invested Capital | OK | 0001528287-26-000030, 0001528287-25-000032 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001528287-26-000030 |
| Current Ratio | 4.94x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.88x | (Cash + Short-term Investments) / Total Debt | OK | 0001528287-26-000030 |
| Revenue per Diluted Share | $2.69 | Revenue / Diluted Shares | OK | 0001528287-26-000030, 0001528287-25-000032 |